Breast cancer is more common in European Americans (EAs) than in African Americans
(AAs) but mortality from breast cancer is higher among AAs. While there are racial …

Abstract Background: African American (AA) women are diagnosed with more advanced
breast cancers and have worse survival than white women, but a comprehensive …

American women of African ancestry (AA) are more likely than European-Americans (EA) to
be diagnosed with aggressive, estrogen receptor (ER) negative breast tumors; mechanisms …

Aberrant DNA methylation is a key feature of breast carcinoma. We aimed to test the
association between breast cancer risk and epigenome-wide methylation in DNA from …

Simple Summary As known breast cancer risk factors do not accurately predict the risk of
developing breast cancer, breast cancer screening is still based solely on age. At the …

Age is a key risk factor for breast cancer and epigenetic alterations may contribute to age-
related increases in breast cancer risk, though the relation of age-related methylation in …

Background We examined whether differences in tumor DNA methylation were associated
with more aggressive hormone receptor-negative breast cancer in an ethnically diverse …

Aberrant DNA methylation constitutes a well‐established epigenetic marker for breast
cancer. Changes in methylation early in cancer development may be clinically relevant for …

Background DNA methylation is a potential biomarker for early detection of breast cancer.
However, robust evidence of a prospective relationship between DNA methylation patterns …

Background DNA methylation plays a critical role in breast cancer development. Previous
studies have identified DNA methylation marks in white blood cells as promising biomarkers …